Reference | Outcome | Tier a | Risk of bias domains b | ||||||
---|---|---|---|---|---|---|---|---|---|
Reference | Design | Outcome | Tier | Confidence in exposure (KEY) | Confidence in outcome (KEY) | Confounding (KEY) d | Appropriate comparison groups | Attrition | Other threats to internal validity |
Cohort studies | |||||||||
Dion et al. (2018) | PC | IQ | 1 | + | + | + | + | − | + |
Miyake et al. (2022) | PC | Behaviour | 1 | + | + | + | + | − | + |
Rahman et al. (2017) | PC | IQ | 1 | + | ++ | + | + | + | + |
PC | Behaviour | 1 | + | ++ | + | + | + | + | |
Schullehner et al. (2020) | PC | ADHD | 1 | + | ++ | + | + | + | + |
Rodrigues et al. (2016) | PC | Neurodevelopment | 2 | + | + | − | + | − | + |
Cross‐sectional studies | |||||||||
Bouchard et al. (2011) | CS | IQ | 1 | + | ++ | + | + | + | + |
Bouchard et al. (2018) | CS | IQ | 1 | + | ++ | + | + | + | + |
Khan et al. (2011) | CS | Behaviour | 1 | + | + | + | + | + | + |
Oulhote et al. (2014) | CS | Memory | 1 | + | + | + | + | + | + |
CS | Attention | 1 | + | + | + | + | + | + | |
CS | Motor | 1 | + | + | + | + | + | + | |
CS | Hyperactivity | 1 | + | + | + | + | + | + | |
Dion et al. (2016) | CS | MRI | 2 | + | ++ | − | + | + | + |
Wasserman et al. (2004) | CS | IQ | 1 | + | + | + | + | + | + |
Wasserman et al. (2006) | CS | IQ | 1 | + | + | + | + | + | + |
Wasserman et al. (2011) | CS | IQ | 1 | + | ++ | + | + | + | + |
Khan et al. (2012) | CS | Academic achievement | 2 | + | + | − | + | + | + |
Kondakis et al. (1989) | CS | Neurological symptoms | 2 | − | + | − | + | + | + |
Nascimento et al. (2016) | CS | Cognitive function | 2 | + | + | − c | + | + | + |
Parvez et al. (2011) | CS | Motor function | 2 | + | ++ | − | + | + | + |
Vieregge et al. (1995) | CS | Neurological symptoms | 2 | + | ++ | − | + | − | + |
Nascimento et al. (2015) | CS | IQ | 3 | + | NR | −− | − | + | + |
Abbreviations: ADHD, attention‐deficit hyperactivity disorder; CS, cross‐sectional; IQ, intelligence quotient; PC, prospective cohort.
The individual rating for each question was combined by an algorithm and translated to an overall tier of reliability for each individual study (RoB tier 1: low RoB; RoB tier 2: moderate RoB; RoB tier 3: high RoB).
Expert judgement was translated into a rating scale for each question to be answered as follows: (++): definitely low RoB; (+): probably low RoB; (NR): not reported; (−): probably high RoB; (− −): definitively high RoB.
Different from the preparatory work, the Panel identified cause for concern regarding the risk for confounding.
For pregnancy and children studies, the following factors were considered as key confounders: offspring age, offspring sex, maternal (or parental) socioeconomic status and/or education, prematurity (conditional), maternal smoking (conditional), maternal alcohol consumption (conditional), parity/number of siblings (conditional), other contaminants (conditional), birth weight (conditional); for pregnancy and children studies, the following factors were considered as key confounders: age at outcome assessment, sex, socioeconomic status and/or education, smoking, ethnicity (conditional), other contaminants (conditional).